Drug-labels.com

Septa-Candesartan HCTZ: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
32 mg / 12.5 mg, 32 mg / 25 mg

Patient Medication Information: uses, side effects, how to take - Septa-Candesartan HCTZ

What the medication is used for:

SEPTA-CANDESARTAN HCTZ lowers high blood pressure.

What it does:

SEPTA-CANDESARTAN HCTZ contains a combination of 2 drugs, candesartan cilexetil and hydrochlorothiazide.

  • Candesartan is an angiotensin receptor blocker (ARB). You

    can recognize an ARB because its medicinal ingredient ends in “-SARTAN”. It lowers blood pressure.

  • Hydrochlorothiazide is a diuretic or “water pill” that

    increases urination. This lowers blood pressure.

This medicine does not cure high blood pressure. It helps to control it. Therefore, it is important to continue taking SEPTA-CANDESARTAN HCTZ regularly even if you feel fine.

When it should not be used:

Do not take SEPTA-CANDESARTAN HCTZ if you:

  • are allergic candesartan cilexetil, hydrochlorothiazide or to any

    non-medicinal ingredient in the formulation.

  • Are allergic to any sulphonamide-derived drugs (sulfa drugs);

    most of them have a medicinal ingredient that ends in “-MIDE”.

  • Are already taking a blood pressure-lowering medicine that

    contains aliskiren (such as Rasilez) and you have diabetes or kidney disease.

  • Have experienced an allergic reaction (angioedema) with

    swelling of the hands, feet, or ankles, face, lips , tongue, throat or sudden difficulty breathing or swallowing to any ARB (any drug in the same class as candesartan cilexetil). Be sure to tell your doctor, nurse, or pharmacist that this has happened to you.

  • Have difficulty urinating or produce no urine.
  • Are pregnant or intend to become pregnant. Taking SEPTA-

    CANDESARTAN HCTZ during pregnancy can cause injury and even death to your baby.

  • Are breastfeeding. SEPTA-CANDESARTAN HCTZ passes into

    breast milk.

  • Have one of the following rare hereditary diseases:

    o Galactose intolerance

    o Lapp lactase deficiency

    o Glucose-galactose malabsorption

    • Because lactose is a non-medicial ingredient in SEPTA-

      CANDESARTAN HCTZ.

What the medicinal ingredients are:

Candesartan cilexetil and hydrochlorothiazide.

What the non-medicinal ingredients are:

Lactose monohydrate, corn starch, carboxymethylcellulose calcium, hydroxypropyl cellulose, magnesium stearate, iron oxide yellow (32 mg / 12.5 mg), iron oxide red (32 mg / 25 mg) and polyethylene glycol.

What dosage forms it comes in:

Tablets in two strengths:

candesartan cilexetil/hydrochlorothiazide 32 mg/12.5 mg candesartan cilexetil/hydrochlorothiazide 32 mg/25 mg

BEFORE you use SEPTA-CANDESARTAN HCTZ talk to your doctor, nurse or pharmacist if you:

  • Are allergic to any drug used to lower blood pressure, including angiotensin converting enzyme (ACE) inhibitors, or penicillin.
  • Are taking a medicine that contains aliskiren, such as Rasilez, used to lower high blood pressure. The combination with SEPTA-CANDESARTAN HCTZ is not recommended.
  • Are taking an angiotensin converting enzyme inhibitor (ACEI).

    You can recognize ACEIs because their medicinal ingredient ends in ‘-PRIL’.

  • Have narrowing of an artery or a heart valve.
  • Have heart failure.
  • Have diabetes, liver, heart or kidney disease.
  • Have lupus or gout.
  • Are on dialysis.
  • Are dehydrated or suffer from excessive vomiting, diarrhea or sweating.
  • Are taking a salt substitute that contains potassium, potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill”).
  • Are on a low-salt diet.
  • Are less than 18 years old.
  • Are having any kind of surgery or dental procedure with anesthesia.
  • Have had a heart attack or stroke.

Hydrochlorothiazide in SEPTA-CANDESARTAN HCTZ can cause Sudden Eye Disorders:

ABOUT THIS MEDICATION

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions-Pregnancy

SEPTA-CANDESARTAN HCTZ should not be used during pregnancy. If you discover that you are pregnant while taking SEPTA-CANDESARTAN HCTZ, stop taking the medication and contact your physician, nurse or pharmacist as soon as possible.

  • Myopia: sudden nearsightedness or blurred vision.
  • Glaucoma: an increased pressure in your eyes, eye pain.

    Untreated, it may lead to permanent vision loss.

These eye disorders are related and can develop within hours to weeks of starting SEPTA-CANDESARTAN HCTZ.

You may become sensitive to the sun while taking SEPTA-CANDESARTAN HCTZ. Exposure to sunlight should be minimized until you know how you respond.

Driving and using machines: Before you perform tasks which may require special attention, wait until you know how you respond to SEPTA-CANDESARTAN HCTZ. Dizziness, lightheadedness, or fainting can especially occur after the first dose and when the dose is increased.

As with most medicines, interactions with other drugs are possible. Tell your doctor or nurse or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.

The following may interact with SEPTA-CANDESARTAN HCTZ:

  • Adrenocorticotropic hormone (ACTH) used to treat West

    Syndrome.

  • Alcohol, barbiturates (sleeping pills), or narcotics (strong

    pain medications). They may cause low blood pressure and dizziness when you go from lying or sitting to standing up.

  • Amantadine.
  • Amphotericin B, an antifungal drug.
  • Anticancer drugs, including cyclophosphamide and

    methotrexate.

  • Antidepressants, in particular selective serotonin reuptake

    inhibitors (SSRIs), including citalopram, escitalopram and sertraline.

  • Antidiabetic drugs, including insulin and oral medicines.
  • Bile acid resins used to lower cholesterol.
  • Other blood pressure lowering drugs, including diuretics

    (“water pills”), aliskiren-containing products (e.g. Rasilez), or angiotensin converting enzyme inhibitors (ACEIs). When taken in combination with ATACAND PLUS, they may cause excessively low blood pressure.

  • Calcium or vitamin D supplements.
  • Corticosteroids used to treat joint pain and swelling.
  • Cyclosporine.
  • Digoxin, a heart medication.
  • Drugs that slow down or speed up bowel function,

    including atropine, biperiden, domperidone and metoclopramide.

  • Drugs used to treat epilepsy, including carbamazepine and

    topiramate.

  • Gout medications, including allopurinol and probenecid.
  • Lithium used to treat bipolar disease.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs), used to

    reduce pain and swelling. Examples include ibuprofen, naproxen and celecoxib.

  • Pressor amines such as norepinephrine.

    • Skeletal muscle relaxants used to relieve muscle spasms, including tubocurare.

Take SEPTA-CANDESARTAN HCTZ exactly as prescribed. It is recommended to take your dose at about the same time everyday.

SEPTA-CANDESARTAN HCTZ can be taken with or without food but it should be taken the same way each day. Swallow SEPTA-CANDESARTAN HCTZ with a glass of water.

If SEPTA-CANDESARTAN HCTZ causes upset stomach, take it with food or milk.

The blister package protects each tablet. When you first open the package, if you find any damage to the plastic seal or foil which exposes the tablet, ask your pharmacist to check the package.

Do not transfer SEPTA-CANDESARTAN HCTZ to other pill containers. To protect your SEPTA-CANDESARTAN HCTZ tablets, keep them in the container received from your farmacist.

Remember to get a new prescription from your doctor or a refill from your pharmacy a few days before all your tablets are taken.

Usual Adult Dose:

Usual maintenance dose is: 1 tablet daily

The dosage of SEPTA-CANDESARTAN HCTZ is individualized.

SEPTA-CANDESARTAN HCTZ is not for initial therapy. You must first be stabilized on the individual components (candesartan cilexetil and hydrochlorothiazide) of SEPTA-CANDESARTAN HCTZ.

INTERACTIONS WITH THIS MEDICATION

PROPER USE OF THIS MEDICATION

Overdose:

Missed dose:

If you miss a dose of SEPTA-CANDESARTAN HCTZ and remember within 12 hours, you should take your usual dose as soon as possible. Then go back to your regular schedule. But if it is more than 12 hours when you remember, do not take the missed dose. Just take the next dose on time. Do not double dose.

Side effects may include:

  • back or leg pain, muscle cramps, spasms and pain, weakness, restlessness
  • dizziness, pins and needles in your fingers, headache
  • constipation, diarrhea, nausea, vomiting, decreased appetite, upset stomach, enlargement of the glands in your mouth
  • bleeding under skin, rash, red patches on the skin
  • drowsiness, insomnia
  • reduced libido
  • throat infections

If any of these affects you severely, tell your doctor, nurse or pharmacist.

SEPTA-CANDESARTAN HCTZ can cause abnormal blood test results. Your doctor will decide when to perform blood tests and will interpret the results.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN
AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor, nurse or pharmacistStop taking drug and seek immediate emergency medical assistance

Only if

severe

In all cases
Common

Low Blood

Pressure:

dizziness, fainting, lightheadedness

May occur when you go from lying or sitting to

standing up

Decreased or
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN
AND WHAT TO DO ABOUT THEM

Symptom / effect increased levels of potassium in the blood:

irregular heartbeats, muscle weakness and generally feeling unwell

Tachycardia:

increased heart beats

Edema: swelling of hands, ankles or feet

Talk with your doctor, nurse or pharmacistStop taking drug and seek
Un-commonAllergic reactions: rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing
Kidney Disorder: change in frequency of urination, nausea, vomiting, swelling of extremities, fatigue
Liver Disorder: yellowing of the skin or eyes, dark urine, abdominal pain, nausea, vomiting, loss of appetite
Increased blood sugar: frequent, urination, thirst, and hunger

Electrolyte

Imbalance:

weakness, drowsiness, muscle pain or cramps, irregular heartbeat

Rare

Rhabdomyolysis:

muscle pain that you cannot explain, muscle tenderness or weakness, dark brown urine

Decreased White Blood Cells:

infections, fatigue, fever, aches, pains

If you think you have taken too much SEPTA-CANDESARTAN HCTZ contact your doctor, nurse, pharmacist, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN
AND WHAT TO DO ABOUT THEM

Symptom / effect

and flu-like

symptoms

Decreased

Platelets:

bruising, bleeding, fatigue and

weakness

Talk with your doctor, nurse or pharmacistStop taking drug and seek
Very rare

Toxic Epidermal Necrolysis:

severe skin

peeling, especially in the mouth and eyes

Unknown

Eye disorders:

-Myopia:

sudden near

sightedness or blurred vision -Glaucoma:

increased pressure in your eyes, eye pain

Anemia:

fatigue, loss of energy, weakness, shortness of breath

Inflammation of the Pancreas: abdominal pain that lasts and gets worse when you lie down, nausea, vomiting

This is not a complete list of side effects. For any unexpected effects while taking SEPTA-CANDESARTAN HCTZ, contact your doctor, nurse or pharmacist.

  • Although SEPTA-CANDESARTAN HCTZ tablets are

    protected in their package, it is best to store them at normal room temperature between 15 and 30°C and in a dry place. Do not keep SEPTA-CANDESARTAN HCTZ in the bathroom.

  • Keep SEPTA-CANDESARTAN HCTZ out of reach of

    children. Never take medicine in front of small children as they will want to copy you.

  • Do not keep or use SEPTA-CANDESARTAN HCTZ after the

    expiry date indicated on the package. Unused medicines, which you know you will no longer need, should be carefully discarded. You may wish to seek advice from your pharmacist.

    This document, plus the full Product Monograph prepared for health professionals, can be found at: www.septapharmaceuticals.com / or by contacting the sponsor, Septa Pharmaceuticals Inc, at: 1-905-564-5665 or by email, at: info@septapharmaceuticals.com

    Please check our website to see if more up-to-date information has been posted.

    Septa Pharmaceuticals Inc.

    7490 Pacific Circle, #1

    Mississauga, ON L5T 2A3

    Canada

    .

    Date of Preparation : April 22, 2015

HOW TO STORE IT

REPORTING SUSPECTED SIDE EFFECTS You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

Report online at www.healthcanada.gc.ca/medeffect Call toll-free at 1-866-234-2345

Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to:

    Canada Vigilance Program

    Health Canada

    Postal Locator 0701E

    Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at

www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02440261

Revision date stated in the text: April 22, 2015

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Septa-Candesartan HCTZ

Rx or OTC
Prescription (Rx)?
DIN 02440261, 02440288
Schedule(s) PRESCRIPTION
Active ingredient(s) Candesartan cilexetil, Hydrochlorothiazide
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09D Angiotensin II receptor blockers (ARBs), combinations
        1. C09DA Angiotensin II receptor blockers (ARBs) and diuretics
          1. C09DA06 Candersartan and diuretics
Company SEPTA PHARMACEUTICALS INC
Current status Approved
Current status date April 29, 2015
Strengths and forms
DIN Strength Dosage form(s) Current status
02440261 32 MG / 12.5 MG Tablet Approved April 29, 2015
02440288 32 MG / 25 MG Tablet Approved April 29, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.